Faculty from Memorial Sloan Kettering Cancer Center, Dana-Farber Cancer Institute, MD Anderson Cancer Center, University of Chicago, University of Pennsylvania and Florida International University are joining Miami Cancer Institute Jan. 24-25 for its inaugural Symposium on Immunotherapies for Hematologic Malignancies.
In two back-to-back, all-day meetings, the FDA Oncologic Drugs Advisory Committee considered four thorny applications that the agency appeared to have been saving up as a result of the pause in activity that followed President Trump’s return to office.
